166 related articles for article (PubMed ID: 35715547)
21. Cost effectiveness of prevaccination screening of health care workers for immunity to measles, rubella and mumps.
Ferson MJ; Robertson PW; Whybin LR
Med J Aust; 1994 Apr; 160(8):478-82. PubMed ID: 8170422
[TBL] [Abstract][Full Text] [Related]
22. Assessment of immune status against measles, mumps, and rubella in young Kuwaitis: MMR vaccine efficacy.
Madi N; Altawalah H; Alfouzan W; Al-Nakib W; Al-Roumi E; Jeragh A
J Med Virol; 2020 Aug; 92(8):963-970. PubMed ID: 31919861
[TBL] [Abstract][Full Text] [Related]
23. Interpreting serological surveys using mixture models: the seroepidemiology of measles, mumps and rubella in England and Wales at the beginning of the 21st century.
Vyse AJ; Gay NJ; Hesketh LM; Pebody R; Morgan-Capner P; Miller E
Epidemiol Infect; 2006 Dec; 134(6):1303-12. PubMed ID: 16650326
[TBL] [Abstract][Full Text] [Related]
24. Use of a microquantity enzyme immunoassay in a large-scale study of measles, mumps and rubella immunity in Italy.
Condorelli F; Stivala A; Gallo R; Marino A; Battaglini CM; Messina A; Russo G; Castro A; Scalia G
Eur J Clin Microbiol Infect Dis; 1998 Jan; 17(1):49-52. PubMed ID: 9512184
[TBL] [Abstract][Full Text] [Related]
25. Seroprevalence of measles, mumps & rubella antibodies among 5-10 years old children in north India.
Gupta M; Tripathy JP; Verma M; Singh MP; Kaur R; Ratho RK; Kumar R
Indian J Med Res; 2019 Mar; 149(3):396-403. PubMed ID: 31249206
[TBL] [Abstract][Full Text] [Related]
26. Seroprevalence survey of measles, rubella, varicella, and mumps antibodies in health care workers and evaluation of a vaccination program in a tertiary care hospital in Japan.
Asari S; Deguchi M; Tahara K; Taniike M; Toyokawa M; Nishi I; Watanabe M; Iwatani Y; Makimoto K
Am J Infect Control; 2003 May; 31(3):157-62. PubMed ID: 12734521
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of antibodies against measles, mumps and rubella in the childhood population in Singapore, 2008-2010.
Ang LW; Lai FY; Tey SH; Cutter J; James L; Goh KT
Epidemiol Infect; 2013 Aug; 141(8):1721-30. PubMed ID: 22999024
[TBL] [Abstract][Full Text] [Related]
28. Prevaccination antibody screening and immunization program for healthcare personnel against measles, mumps, rubella, and varicella in a Japanese tertiary care hospital.
Kanamori H; Tokuda K; Ikeda S; Endo S; Ishizawa C; Hirai Y; Takahashi M; Aoyagi T; Hatta M; Gu Y; Yano H; Weber DJ; Kaku M
Tohoku J Exp Med; 2014 Oct; 234(2):111-6. PubMed ID: 25224029
[TBL] [Abstract][Full Text] [Related]
29. Measles and Rubella Seroprevalence Among HIV-infected and Uninfected Zambian Youth.
Sutcliffe CG; Searle K; Matakala HK; Greenman MP; Rainwater-Lovett K; Thuma PE; Moss WJ
Pediatr Infect Dis J; 2017 Mar; 36(3):301-306. PubMed ID: 27879554
[TBL] [Abstract][Full Text] [Related]
30. Serological survey of measles and rubella immunity in Sydney preschool children.
Causer J; Mira M; Karr M; Hueston L; Burgess M; Alperstein G; Fett M; Cunningham A
J Paediatr Child Health; 2000 Oct; 36(5):418-21. PubMed ID: 11036793
[TBL] [Abstract][Full Text] [Related]
31. Seroprevalence of antibodies to measles, mumps, and rubella among Thai population: evaluation of measles/MMR immunization programme.
Tharmaphornpilas P; Yoocharean P; Rasdjarmrearnsook AO; Theamboonlers A; Poovorawan Y
J Health Popul Nutr; 2009 Feb; 27(1):80-6. PubMed ID: 19248651
[TBL] [Abstract][Full Text] [Related]
32. [Age-related seroprevalence of measles, mumps and rubella antibodies in 1996].
Zäch K; Nicoara C; Germann D; Matter L
Schweiz Med Wochenschr; 1998 Apr; 128(17):649-57. PubMed ID: 9622837
[TBL] [Abstract][Full Text] [Related]
33. Integrating Blood Collection within Household Surveys: Lessons Learned from Nesting a Measles and Rubella Serological Survey within a Post-Campaign Coverage Evaluation Survey in Southern Province, Zambia.
Mutembo S; Carcelen A; Mwansa FD; Searle K; Wanyiri JW; Book C; Thuma PE; Moss WJ; Hayford K
Am J Trop Med Hyg; 2018 Dec; 99(6):1639-1642. PubMed ID: 30277204
[TBL] [Abstract][Full Text] [Related]
34. Seroprevalence of Measles, Mumps, and Rubella Antibodies in College Students in Mumbai, India.
Gohil DJ; Kothari ST; Chaudhari AB; Gunale BK; Kulkarni PS; Deshmukh RA; Chowdhary AS
Viral Immunol; 2016 Apr; 29(3):159-63. PubMed ID: 26910764
[TBL] [Abstract][Full Text] [Related]
35. MMR vaccination, measles epidemiology and sero-surveillance in the Republic of Ireland.
Johnson H; Hillary IB; McQuoid G; Gilmer BA
Vaccine; 1995 Apr; 13(6):533-7. PubMed ID: 7483773
[TBL] [Abstract][Full Text] [Related]
36. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.
Peltola H; Heinonen OP; Valle M; Paunio M; Virtanen M; Karanko V; Cantell K
N Engl J Med; 1994 Nov; 331(21):1397-402. PubMed ID: 7969278
[TBL] [Abstract][Full Text] [Related]
37. Seroprevalence of measles, mumps and rubella antibodies in Luxembourg: results from a national cross-sectional study.
Mossong J; Putz L; Schneider F
Epidemiol Infect; 2004 Jan; 132(1):11-8. PubMed ID: 14979584
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of antibodies against measles, mumps, and rubella before and after vaccination of school-age children with three different triple combined viral vaccines, Rio Grande do Sul, Brazil, 1996.
dos Santos BA; Stralioto SM; Siqueira MM; Ranieri TS; Bercini M; Schermann MT; Wagner MB; Silveira TR
Rev Panam Salud Publica; 2006 Nov; 20(5):299-306. PubMed ID: 17316487
[TBL] [Abstract][Full Text] [Related]
39. Measles, mumps, rubella prevention: how can we do better?
Kauffmann F; Heffernan C; Meurice F; Ota MOC; Vetter V; Casabona G
Expert Rev Vaccines; 2021 Jul; 20(7):811-826. PubMed ID: 34096442
[TBL] [Abstract][Full Text] [Related]
40. Seroprevalence of anti-rubella and anti-measles IgG antibodies in pregnant women in Shiraz, Southern Iran: outcomes of a nationwide measles-rubella mass vaccination campaign.
Honarvar B; Moghadami M; Moattari A; Emami A; Odoomi N; Bagheri Lankarani K
PLoS One; 2013; 8(1):e55043. PubMed ID: 23383049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
